DexCom Other Non-Current Liabilities increased by 3.4% to $141.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.7%, from $150.30M to $141.80M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 11.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.70M | $98.50M | $90.00M | $97.10M | $99.50M | $123.30M | $128.30M | $129.70M | $133.10M | $133.90M | $125.60M | $129.40M | $128.10M | $129.60M | $147.90M | $150.30M | $151.60M | $147.40M | $137.10M | $141.80M |
| QoQ Change | — | +12.3% | -8.6% | +7.9% | +2.5% | +23.9% | +4.1% | +1.1% | +2.6% | +0.6% | -6.2% | +3.0% | -1.0% | +1.2% | +14.1% | +1.6% | +0.9% | -2.8% | -7.0% | +3.4% |
| YoY Change | — | — | — | — | +13.5% | +25.2% | +42.6% | +33.6% | +33.8% | +8.6% | -2.1% | -0.2% | -3.8% | -3.2% | +17.8% | +16.2% | +18.3% | +13.7% | -7.3% | -5.7% |